Dong-E-E-JiaoLtd (000423) Stock Overview
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
000423 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
100% Patient Improvement in trial puts this $16M Biotech on the radar
Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.
Dong-E-E-Jiao Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥47.40 |
| 52 Week High | CN¥67.70 |
| 52 Week Low | CN¥46.09 |
| Beta | 0.28 |
| 1 Month Change | -3.60% |
| 3 Month Change | -7.57% |
| 1 Year Change | -23.18% |
| 3 Year Change | 46.34% |
| 5 Year Change | 12.64% |
| Change since IPO | 2,862.11% |
Recent News & Updates
Recent updates
Little Excitement Around Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Earnings
Jan 31
We Think Dong-E-E-JiaoLtd's (SZSE:000423) Robust Earnings Are Conservative
Nov 06Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Shares Climb 34% But Its Business Is Yet to Catch Up
Oct 14Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Shares Could Be 37% Below Their Intrinsic Value Estimate
Sep 13Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results
Mar 25Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio
Mar 21Shareholder Returns
| 000423 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.4% | 0.7% | 1.8% |
| 1Y | -23.2% | 17.6% | 24.1% |
Return vs Industry: 000423 underperformed the CN Pharmaceuticals industry which returned 17.6% over the past year.
Return vs Market: 000423 underperformed the CN Market which returned 24.1% over the past year.
Price Volatility
| 000423 volatility | |
|---|---|
| 000423 Average Weekly Movement | 2.7% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 000423 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000423's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 4,095 | Jinni Sun | www.dongeejiao.com |
Dong-E-E-Jiao Co.,Ltd. engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China. Its products include Ejiao, a Chinese tonic herbal medicine; compound donkey-hide gelatin paste; a donkey-hide gelatin cake under Peach Blossom Princess name; instant donkey-hide gelatin powder; donkey-hide gelatin, meat, and pineapple puree under the Zhuangben brand name; and brain and kidney nourishing oral liquid, as well as medical insurance products, such as tortoise shell glue and deer antler glue.
Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary
| 000423 fundamental statistics | |
|---|---|
| Market cap | CN¥30.45b |
| Earnings (TTM) | CN¥1.64b |
| Revenue (TTM) | CN¥6.22b |
Is 000423 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000423 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.22b |
| Cost of Revenue | CN¥1.72b |
| Gross Profit | CN¥4.51b |
| Other Expenses | CN¥2.87b |
| Earnings | CN¥1.64b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.55 |
| Gross Margin | 72.42% |
| Net Profit Margin | 26.29% |
| Debt/Equity Ratio | 0% |
How did 000423 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 00:34 |
| End of Day Share Price | 2025/09/30 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dong-E-E-Jiao Co.,Ltd. is covered by 32 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anthony Lok | BOCI Research Ltd. |
| Jessica Li | BofA Global Research |
| Yanyin Zhu | China International Capital Corporation Limited |